Industry News and Events

Breaking News January 2018



New Directions Technology Consulting
The dental industry is undergoing many of the same types of disruptions as all of healthcare, and NDTC's involvement with in the dental industry continues. We have worked on initiatives to improve access to dental treatment and to oral-care information, ...
New Directions Technology Consulting
October 2018: Inhalation magazine: “Connected inhalers: Stakeholders’ potential benefits and possible concerns.” Multiple, competing inhaler treatment products make inhaler use more complex for patients. This is analogous to having multiple epinephrine auto-injector choices. Read more: https://lnkd.in/g-9JJcW? #articles #inhalation #inhaler
New Directions Technology Consulting
Beyond Manufacturing: Industrialisation of Drug Delivery in the Real World August 2018, ONdrugDELIVERY: on the industrialization of drug delivery. https://lnkd.in/eyG-YmG #drugdelivery #beyondmanufacturing #article #goodread
The industrialisation of drug delivery extends well beyond the research lab and production facility. Healthcare, including pharma in the ...
New Directions Technology Consulting
Gearing Up for DDP...Plans are shaping up for New Directions and colleagues to attend Drug Delivery Partnerships in the new year. More information to come after we attend some November meetings in Europe. https://lnkd.in/gc4PSZz #conferences #drugdelivery
New Directions Technology Consulting
2018 PDA Universe of Pre-Filled Syringes and Injection Devices PDA Universe Is Right Around the Corner: New Directions will attend the PDA Universe conference and the two workshops, October 8-11, in Orlando, Fla. Many recent newsworthy events, such as new FDA complex generic and innovator approvals, as well as ...
New Directions Technology Consulting
NDTC Partnership News: Aterica Digital Health an NDTC (New Directions) partner, is showcasing its digital health platform during a nationwide U.S. rollout of its first product, Veta Smart Case & App for epinephrine auto-injectors.

Aterica’s licensing of the mMed Patent ...